Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

Overview

About this study

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with radiation therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Treated at Mayo Clinic in Radiation Oncology.
  • Radiation therapy for curative intent.

Exclusion Criteria:

  • None.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nadia Laack, M.D.

Closed for enrollment

Contact information:

Adam Amundson

(507)293-1826

Amundson.Adam1@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Carlos Vargas, M.D.

Closed for enrollment

Contact information:

Heather Young CCRP

(480)342-4629

Young.Heather@mayo.edu

Albert Lea, Minn.

Mayo Clinic principal investigator

Timothy Kozelsky, M.D.

Closed for enrollment

Contact information:

Adam Amundson

(507)293-1826

Amundson.Adam1@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20147875

Mayo Clinic Footer